Ligustroflavone
CAS No. 260413-62-5
Ligustroflavone ( Nuezhenoside )
Catalog No. M18322 CAS No. 260413-62-5
Ligustroflavone has anti-inflammatory activity.
Purity : 98%
Size | Price / USD | Stock | Quantity |
5MG | 87 | In Stock |
|
10MG | 147 | In Stock |
|
25MG | 248 | In Stock |
|
50MG | 357 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLigustroflavone
-
NoteResearch use only, not for human use.
-
Brief DescriptionLigustroflavone has anti-inflammatory activity.
-
DescriptionLigustroflavone has anti-inflammatory activity.
-
SynonymsNuezhenoside
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number260413-62-5
-
Formula Weight724.67
-
Molecular FormulaC33H40O18
-
Purity98%
-
Solubility——
-
SMILESc1(cc(=O)c2c(cc(cc2o1)O[C@@H]1O[C@@H]([C@H]([C@@H]([C@H]1O[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)C)O)O)CO[C@@H]1O[C@H]([C@@H]([C@H]([C@H]1O)O)O)C)O)c1ccc(cc1)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Magnolignan A
Magnolignan A-2-O-beta-D-glucopyranoside has medium cytotoxic activity against HEp-2 and HepG2 cells, with IC(50) of 13.3 microM, and 46.4 microM, respectively.
-
GPRP acetate
GPRP acetate is fibrinogen-related peptides, which inhibit the interaction of fibrinogen with the platelet membrane glycoprotein IIbIIIa complex (GPIIbIIIa).
-
Syk Inhibitor II hyd...
The impact of spleen tyrosine kinase (Syk) signaling might be prominent in lupus because (i) Syk is a shared downstream signaling molecule among circulating immune complex, LPS, and (1→3)-β-D-glucan (BG), and (ii) all of these factors are detectable in the serum of Fc gamma receptor IIb-deficient (FcgRIIb-/-) mice with sepsis. Syk inhibition downregulated several inflammatory pathways in FcgRIIb-/- macrophages activated with BG + LPS suggesting the potential anti-inflammatory impact of Syk inhibitors in lupus.